MNS is a selective inhibitor of c-Src and Syk tyrosine kinases also known as 3,4-methylenedioxy-β-nitrostyrene. MNS acts as a cell-permeable cytotoxic β-nitrostyrene derivative which suppresses human platelet aggregation. In addition, platelets previously aggregated by ADP, U46619, arachidonic acid, collagen, thrombin, ionophore A23187, and PDBu can be disaggregated by MNS. Studies suggest the mechanism responsible for this inhibition is observed via prevention of glycoprotein IIb/IIIa activation.
1. Wang, W.Y., et al. 2006. Mol. Pharmacol. 70: 1380-1389. PMID: 16837624
2. Hsieh, P.W., et al. 2010. Bioorg. Med. Chem. 18: 7621-7627. PMID: 20850977
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.